Menu
Trial Execution Services (TES)

Multi-faceted acceleration for your clinical trial

In 2016, the Global Alzheimer’s Platform Foundation (GAP) began working with pharmaceutical sponsors to speed up the delivery, increase the efficacy, and reduce the cost of neurodegenerative clinical trials.

The TES Recruitment Funnel
Primary CareAssisted Living FacilitySpecialty PhysicianCommunity Partner
HCP EngagementMRUsMemory ScreensEarned/Paid Digital Media
Research referrals
GAP-Net Sites
GAP's Brain Health Registry
Partner Coalitions
Data-Driven & Diverse Recruitment Strategies
Targeted Network of Experts
Trial Execution Services

In a fast-moving field, GAP continues to pioneer new approaches to clinical trials that help research sites succeed and make it easier for volunteers to take part.

Our Trial Execution Services (TES) team brings together three areas of expertise essential to clinical trial implementation. Working closely with each site we support, TES builds precision recruitment plans tailored to every protocol, study population, and sponsor objective. Because no two studies are alike, GAP develops bespoke recruitment strategies rather than standardized ones, grounded in community-earned trust to reach the best participants for your clinical trial.

Working with GAP means your study has support from:

  • study start up to last participant in
  • community members attending an outreach activity to being enrolled (and randomized!) in a trial
  • site selection to the data lock

With a network of 75+ sites, including several of our own, GAP has over a decade of measured, successful strategies that have redefined what it means to conduct clinical trials.

TES by the numbers

Measured, successful strategies.

Data as of October 2026
Each dot = 100 participants
0

Participants referred to sites

0%

Average understudied populations (USP) enrolled per trialPhase II–III & Prescreening studies

GAP-Net sites0.49
Non-GAP sites0.39
0per site / month

Average randomizations at GAP-Net sites, compared to 0.39 for Non-GAP sites

Up to0months

Of recruitment time saved using TES

Within0days

Study start-up (SSU)

Our TES team

Three Pillars of Study Success

GAP Participant Services
GPS

GAP Participant Services

Created in 2017, our inaugural GAP program, GAP Participant Services (GPS), was developed to work with GAP-Net sites to support study implementation, conduct study-related activities or services, and collaborate in increasing participation in clinical trials. Aiding sites in trial support and precision recruitment, the GPS team is comprised of clinical research professionals from across North America who have worked on all phases of clinical trials and are leading experts in the field. The GPS program was a first-of-its-kind in the neurodegenerative field and no one does it better. Using data-driven recruitment strategies built on collaboration with GAP-Net sites, each GAP-enabled trial supports the protocol, population, and sponsor objective.

Our GPS liaisons are also in the field working with healthcare providers through our CNS HCP Provider Connect program to expand the referral pipeline and recruit the RIGHT people, not just more people, living with dementia into studies that could not only help them but help the neurodegenerative field.

GAP Participant Services
Inclusive Research Initiative Community Connectors
IRI

Inclusive Research Initiative

In eight years of supporting clinical trial sites, GAP saw a clear gap: historically underrepresented communities made up only 5% of study populations. These include Black, Hispanic, Asian American, Native American, Pacific Islander, LGBTQIA+, and rural participants. The communities are often 1.5-2x more likely to develop Alzheimer’s disease, and they were not included in the narrative.

In 2022, GAP sought to increase the representation of traditionally understudied communities and created our Inclusive Research Initiative (IRI) program. Our IRI team works with our GAP-Net sites on community-focused recruitment based on earned trust to make sure that our sites position themselves as resources. Using diverse recruitment strategies like community mapping, consistent outreach, online ads, and meeting communities where they are, our team of Community Connectors work slowly and thoughtfully to recruit the RIGHT participants because better representation leads to stronger research, and stronger research means more opportunities for cures and treatments that work for everyone.

Inclusive Research Initiative
THOR Mobile Research Unit
MRUs

Mobile Research Units

Part of our IRI team, GAP has been ‘Taking Health on the Road’ (THOR) with our mobile research units (MRUs) since 2022. THOR’s purpose is to meet communities where they are – helping to facilitate long-term relationships between GAP-Net sites, their community members, and neurodegenerative research as a whole. They provided clinical trial services, brain health resources, and a listening ear to ensure that volunteers, who are often from traditionally understudied communities, have their needs and concerns heard. THOR partners with local advocates, health clinics, churches, community centers, and other participant-focused organizations to work alongside GAP-Net sites to enrich the health and wellness of their neighbors.

Our MRUs are deployed in Florida (THOR East), and California and Arizona (THOR West).

THOR East · Florida THOR West · California & Arizona THOR South
Mobile Research Units
Beyond the core pillars

Supplemental Accelerator Programs

RADDISH

Rapid Alzheimer’s and Dementia Detection, Intervention & Strategic Health
Biomarker testing in the lab

A fully decentralized and/or community-based pre-screening approach RADDISH – Rapid Alzheimer’s and Dementia Detection, Intervention & Strategic Health – leverages digital cognitive assessments, blood-based biomarkers, and telehealth to evaluate candidates for therapeutic dementia, Alzheimer’s disease, and Parkinson’s disease clinical trials that matches participants with suitable GAP-enabled trials enrolling locally.

  • Rapid & comprehensive evaluations of cognitive function AND biomarkers for AD and other CNS diseases
  • Uses Linus Health, rDAC; BrainCheck Screen, & BrainCheck Assess assessments
  • Tests for biomarkers pTau217 & NfL
  • Can include additional, optional tests such as olfactory, RetispecAD eye scan, and more
  • Does a comprehensive review of medical history, current medications, and medical records
  • Evaluations completed within 1-2 weeks via telehealth or locally hosted event
  • Streamlined, efficient, low-burden process for physicians and patients
  • Faster access for participants to either FDA-approved therapies or appropriate trials
  • Reduced pre-screening and clinical costs by leveraging a streamlined process

CNS Provider Connect Program

Engagement, resources and support for community health care providers
Health care provider with a patient

Expanding Options for Providers and Their Patients The Global Alzheimer’s Platform Foundation (GAP) CNS Provider Connect program is a comprehensive, collaborative program built on developing and nurturing meaningful, long-term relationships with healthcare providers. GAP supports providers as they navigate the evolving CNS landscape and integrate emerging diagnostics, treatments, and research opportunities into clinical practice. We do this by identifying real-world barriers and offering solutions and delivering ongoing education, clinical guidance, practical resources, and implementation support. Through trusted partnerships, we hope to empower providers to make informed decisions, expand options for their patients, and connect more individuals with innovative treatments and clinical research opportunities.

  • Builds networks of primary care, neurology, geriatrics, movement disorder, and other community health care providers
  • Builds clinician knowledge and engagement through office visits, lunch-and-learns, webinars, research briefings and case reviews
  • Identifies real-world barriers to blood-based biomarker (BBM) adoption, including reimbursement, lab access, coding, ordering workflows, and education gaps
  • Provides practical implementation support, referral pathways, ordering resources, and ongoing provider follow-up
  • Connects community-based health care providers and their potentially eligible patients with GAP-Net research sites and enrolling clinical trials
  • Generates actionable sponsor insights and measurable outcomes, including providers engaged, office visits, market coverage, barriers identified, test-ordering activity, and referrals
  • Scalable across markets, CNS indications, diagnostics, therapies, and sponsor-specific objective
  • Maintains a growing nationwide provider email database with quarterly CNS newsletters featuring trial opportunities, biomarker updates, workflow resources, CME-accredited webinars, and more
Case study program results
0+
Providers engaged
0+
HCP offices
~0
Days
0
U.S. markets
February – September, 2026
CNS Connect newsletter